Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Augmentation des complications sanitaires graves lors de l’usage non-médical du protoxyde d’azote en France.
Association française des centres d’addictovigilance; Micallef J, Mallaret M, Lapeyre-Mestre M, Daveluy A, Victorri-Vigneau C, Peyrière H, Debruyne D, Deheul S, Bordet R, Chevallier C, Perault-Pochat MC, Le Boisselier R, Libert F, Chaouachi L, Gillet P. Association française des centres d’addictovigilance, et al. Among authors: mallaret m. Therapie. 2021 Jan-Feb;76(1):53-54. doi: 10.1016/j.therap.2020.01.001. Epub 2020 Jan 17. Therapie. 2021. PMID: 32005483 French. No abstract available.
Warning on increased serious health complications related to non-medical use of nitrous oxide.
French Association of Addictovigilance Centres; Micallef J, Mallaret M, Lapeyre-Mestre M, Daveluy A, Victorri-Vigneau C, Peyrière H, Debruyne D, Deheul S, Bordet R, Chevallier C, Perault-Pochat MC, Le Boisselier R, Libert F, Chaouachi L, Gillet P. French Association of Addictovigilance Centres, et al. Among authors: mallaret m. Therapie. 2021 Sep-Oct;76(5):478-479. doi: 10.1016/j.therap.2020.01.002. Epub 2020 Jan 17. Therapie. 2021. PMID: 32063400 No abstract available.
Addictovigilance contribution during COVID-19 epidemic and lockdown in France.
Lapeyre-Mestre M, Boucher A, Daveluy A, Gibaja V, Jouanjus E, Mallaret M, Peyrière H, Micallef J; French Addictovigilance Network. Lapeyre-Mestre M, et al. Among authors: mallaret m. Therapie. 2020 Jul-Aug;75(4):343-354. doi: 10.1016/j.therap.2020.06.006. Epub 2020 Jun 23. Therapie. 2020. PMID: 32660776 Free PMC article. Review.
[Increase of overdose and deaths related to methadone during COVID-19 epidemic in 2020].
Frauger E, Fouilhé N, Lacroix C, Daveluy A, Le Boisselier R, Bertin C, Revol B, Carton L, Chevalier C, Eiden C, Gibaja V, Aquizerate A, Chaouachi L, Bouquet E, Roussin A, Mallaret M, Micallef J. Frauger E, et al. Among authors: mallaret m. Therapie. 2024 May-Jun;79(3):297-306. doi: 10.1016/j.therap.2023.06.004. Epub 2023 Jun 15. Therapie. 2024. PMID: 37391322 Free PMC article. French.
[Mephedrone: a designer drug of recent use in France].
Debruyne D, Courné MA, Le Boisselier R, Djezzar S, Gérardin M, Boucher A, Karila L, Coquerel A, Mallaret M. Debruyne D, et al. Among authors: mallaret m. Therapie. 2010 Nov-Dec;65(6):519-24. doi: 10.2515/therapie/2010077. Epub 2010 Dec 23. Therapie. 2010. PMID: 21176758 Review. French.
206 results